PH12898A - A composition for the treatment of calcific tumors - Google Patents

A composition for the treatment of calcific tumors

Info

Publication number
PH12898A
PH12898A PH15822A PH15822A PH12898A PH 12898 A PH12898 A PH 12898A PH 15822 A PH15822 A PH 15822A PH 15822 A PH15822 A PH 15822A PH 12898 A PH12898 A PH 12898A
Authority
PH
Philippines
Prior art keywords
treatment
composition
calcific tumors
calcific
tumors
Prior art date
Application number
PH15822A
Other languages
English (en)
Inventor
M Francis
A Tofe
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PH12898A publication Critical patent/PH12898A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH15822A 1973-05-23 1974-05-10 A composition for the treatment of calcific tumors PH12898A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36297173A 1973-05-23 1973-05-23

Publications (1)

Publication Number Publication Date
PH12898A true PH12898A (en) 1979-10-04

Family

ID=23428261

Family Applications (1)

Application Number Title Priority Date Filing Date
PH15822A PH12898A (en) 1973-05-23 1974-05-10 A composition for the treatment of calcific tumors

Country Status (6)

Country Link
BE (1) BE815397A (enExample)
DE (1) DE2424453C3 (enExample)
FR (1) FR2230374A1 (enExample)
NL (1) NL7406952A (enExample)
PH (1) PH12898A (enExample)
ZA (1) ZA743159B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371728C (en) 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6547816B1 (en) 1999-07-12 2003-04-15 Civatech Corporation Formable integral source material for medical devices
EP1255571A1 (en) * 2000-02-18 2002-11-13 Civatech Corporation Formable integral source material for medical and industrial devices
EP1390081A2 (en) 2001-01-08 2004-02-25 Neorx Corporation Therapeutic and diagnostic compounds, compositions, and methods
WO2008027402A2 (en) 2006-08-29 2008-03-06 Civatech Oncology Brachytherapy devices and related methods and computer program products

Also Published As

Publication number Publication date
DE2424453C3 (de) 1981-02-26
BE815397A (fr) 1974-11-22
DE2424453B2 (de) 1980-06-12
FR2230374B1 (enExample) 1978-07-21
DE2424453A1 (de) 1974-12-12
ZA743159B (en) 1975-05-28
FR2230374A1 (en) 1974-12-20
NL7406952A (enExample) 1974-11-26

Similar Documents

Publication Publication Date Title
IL44620A (en) 5-oxa- -aryl-prostaglandin f1 compounds
ZA722506B (en) Tetrachlorophthalide compounds
ZA732683B (en) Therapeutic agent
ZM16774A1 (en) Compounds
JPS52151636A (en) Composition for sensitizing treatment
AU7439274A (en) Catheters
AU7031674A (en) Novel compounds
AU6977274A (en) Compounds
ZA743765B (en) New therapeutical compositions
PH12898A (en) A composition for the treatment of calcific tumors
ZA744888B (en) Therapeutical composition for the treatment of mycobacterioses
GB1407933A (en) Sulphenylation of n-arylheterocyclic compounds
KE2889A (en) Pathalocyanine compounds
IL45739A (en) Process for the priparation of 6-deoxytetracyclines
ZA728251B (en) Composition for the treatment of hyperlipoproteinaemia
AU7040074A (en) Compounds
AU4775472A (en) New polyepoxide-polysiloxane compounds
CA1028246A (en) Compositions for the treatment of calcific tumors
ZA744584B (en) Novel n-hydroxy-amidine compounds
YU151174A (en) Process for the dehalogenization of 11-a-halo-methylene-tetracycline
ZA75607B (en) Pharmaceutical composition for the treatment of cancer
AU7528074A (en) Compounds
AU6677774A (en) Triphenyl-tin compounds
AU6436474A (en) Compounds
GB1408729A (en) Sulphilimine compounds